PsyAccess
Czy się kwalifikuję?
Czy się kwalifikuję?
Ketamina / KAPZweryfikowano w rejestrzeModel ośrodków wyznaczonych

KetaminTherapieZentrum (Schmerzmedizin Luzern)

Luzern, Szwajcaria

Leczenie i dostęp

  • Oferowane terapieKetamina dożylna w bólu przewlekłym · Ketamina dożylna w ciężkiej depresji · Esketamina (Spravato) w aerozolu do nosa · Blokady zwoju gwiaździstego w PTSD · tDCS w depresji i bólu przewlekłym · Interwencyjna terapia bólu
  • Ścieżka dostępuPrywatnie / samodzielna opłata
  • Koszt i finansowanie (status wg rejestru)Na stronie placówki nie ma opublikowanych cen. Praktyka podaje, że ponieważ ketamina nie jest w Szwajcarii zarejestrowana w depresji, ubezpieczenie podstawowe (Grundversicherung) jej nie pokrywa: leczenie zlecone przez psychiatrę prowadzącego wykonywane jest dla samopłacących, a pacjenci z ubezpieczeniem dodatkowym mogą wnioskować u ubezpieczyciela o udział w kosztach. W przypadku esketaminy w aerozolu wskazanie musi ustalić psychiatra prowadzący i złożyć u ubezpieczyciela wniosek o zgodę na pokrycie kosztów (Kostengutsprache).
  • Telefon+41 41 500 73 20
  • Strona internetowahttps://schmerzmedizinluzern.ch

O tej placówce

Poniższe szczegóły profilu są po angielsku.

The KetaminTherapieZentrum is a service of SchmerzMedizinLuzern, a pain medicine practice in Lucerne led by Dr. med. Patrick Willimann. Drawing on more than ten years of experience with ketamine in pain therapy and anesthesia-trained medical and nursing staff, it treats chronic pain and severe depression with intravenous ketamine and is certified for administering intranasal esketamine (Spravato), approved in Switzerland since 2020 as a third-line treatment for severe depression. For depression, the indication must come from the treating psychiatrist, who also files the insurer cost approval request. It additionally offers stellate ganglion blocks for PTSD and tDCS for depression and pain, with day-clinic care in the practice and inpatient treatment available at Hirslanden Klinik St. Anna.

Usługi i programy

Poniższe szczegóły profilu są po angielsku.

  • IV ketamine for chronic painIntravenous ketamine, approved in Switzerland for decades as an analgesic and anesthetic, used for chronic and difficult-to-treat pain within a multimodal pain therapy concept. Not published on the provider's website.
  • IV ketamine for severe depressionPerformed when prescribed by the treating psychiatrist; because ketamine is not approved for depression in Switzerland, treatment is for self-payers, with supplementary-insured patients able to apply to their insurer for a cost contribution. The practice also offers a gentle, slowly dose-escalating esketamine infusion to test response in risk patients or after an initial insurer refusal. Self-pay per the provider; basic insurance does not cover it. No prices published.
  • Esketamine (Spravato) nasal sprayThe practice states it is certified for applying intranasal esketamine, approved in Switzerland since 2020 as a third-line treatment for severe depression. Typical schedule: two sessions per week for four weeks, with intervals extended on success; Swissmedic-required safety measures such as regular blood pressure monitoring are observed, and contraindications include prior stroke, recent heart attack and current suicidality. Insurer cost approval must be requested by the treating psychiatrist; conditions include treatment-resistant depression and failure of at least two antidepressants from different classes at adequate dose and duration. No prices published.
  • Stellate ganglion blocks for PTSDUltrasound-guided local anesthetic blocks of the stellate ganglion, planned as a series and performed only in agreement with the treating psychiatric professionals as one element of PTSD care. Not published on the provider's website.
  • tDCS for depression and painNon-invasive, non-pharmacological transcranial direct current stimulation offered for treatment-resistant depression, medication intolerance and chronic pain. Not published on the provider's website.

Programy i badania

ProgramRodzajStatus
Esketamine (Spravato) nasal spray administration
The practice states it is certified for intranasal esketamine application and notes a September 2021 Swissmedic rule that this therapy may only be carried out in psychiatric practices and clinics; the treating psychiatrist decides the indication and files the insurer cost approval.
esketamine_nasalcertified for administration (per provider)
IV ketamine for depression
Off-label for depression in Switzerland; self-pay, with possible supplementary-insurance cost contribution on application.
ketamine_ivoffered on psychiatrist prescription
IV ketamine for chronic pain
Based on more than ten years of ketamine experience in pain therapy.
ketamine_iv_painoffered

Ceny

Poniższe szczegóły profilu są po angielsku.

PozycjaCena
IV ketamine for depression
Provider states basic insurance does not cover it; self-pay, supplementary-insured patients can apply to their insurer for a cost contribution.
Not published
Esketamine nasal spray
Insurer coverage subject to prior cost approval filed by the treating psychiatrist.
Not published

Ceny pochodzą ze strony internetowej placówki i były ostatnio sprawdzane . Przed rezerwacją zawsze potwierdź aktualną cenę w placówce.

Udogodnienia i języki

Poniższe szczegóły profilu są po angielsku.

  • Udogodnienia
    • Practice on the 2nd floor of the Romerohaus, Kreuzbuchstrasse 44, 6006 Lucerne
    • Day-clinic care available in the practice; inpatient treatment available at Hirslanden Klinik St. Anna
    • Open Mon/Tue/Thu 08:00-12:00 and 13:00-17:00, Wed 08:00-11:00, Fri 08:00-12:00 and 13:00-16:00
  • JęzykiWebsite in German with French and Italian language versions.
  • ZespółMedical lead is Dr. med. Patrick Willimann; the team's physicians and nurses are anesthesia-trained, with over ten years of experience using ketamine in pain therapy.

Częste pytania

Poniższe szczegóły profilu są po angielsku.

Does insurance pay for ketamine against depression here?

No. The practice states that because ketamine is not approved in Switzerland for treating depression, the basic insurance does not cover the costs. If the treatment is prescribed by the treating psychiatrist it can be carried out for self-payers, and patients with supplementary insurance can apply to their insurer for a cost contribution.

What about esketamine (Spravato) coverage?

The treating psychiatrist must establish the indication and file the cost approval request with the insurer. Conditions include a diagnosis of treatment-resistant depression and unsuccessful use of at least two antidepressants from two different classes at sufficient dose and duration.

How do I get treated - can I refer myself?

For depression treatments the indication must come from the treating psychiatrist, and the practice offers to answer psychiatrists' questions directly (041 500 73 20 / schmerzmedizin@hin.ch). For pain conditions the practice runs its own consultation with physician referral and self-referral routes.

Is treatment outpatient or inpatient?

Treatments are outpatient at the practice, complemented by day-clinic care in the practice and, where needed, inpatient treatment at Hirslanden Klinik St. Anna.

How does an esketamine course typically run?

Therapy usually starts with two sessions per week for four weeks, with intervals extended if the therapy succeeds. Each session includes Swissmedic-required safety measures such as regular blood pressure measurement, since strong blood pressure rises and dissociative states are very common side effects.

Rozważasz alternatywy? Other Swiss routes include BAG-designated Spravato centres and hospital interventional psychiatry services, providers with federal limited medical use authorisations for psychedelic-assisted therapy, and clinical trials at university centres.

Weryfikacja

Co najmniej jedno źródło tego wpisu to publiczny rejestr państwowy lub oficjalny rejestr publicznoprawny. Wpis rejestrowy jest podlinkowany poniżej i sprawdzany ponownie co najmniej co 90 dni.

Widzisz błąd? Zobacz naszą metodologię, aby dowiedzieć się, jak sprawdzamy wpisy i jak zgłosić poprawkę.

Sprawdź dopasowanie i wyślij zapytanie

Ketamina / KAP — dostęp (Szwajcaria) opiera się na opublikowanych kryteriach. Najpierw krótka wstępna kwalifikacja — potem Twoje podsumowanie trafia do KetaminTherapieZentrum (Schmerzmedizin Luzern) wyłącznie za Twoją wyraźną zgodą, a niezależnie od decyzji możesz je pobrać dla siebie.

Sprawdź dopasowanie i wyślij zapytanie

Około dwóch minut. Sprawdzenie działa w Twojej przeglądarce — odpowiedzi nie są nigdzie wysyłane, dopóki sam ich nie wyślesz. Liczymy tylko anonimowe zdarzenia użycia.

Sprawdź dopasowanie i wyślij zapytanie